Advertisement

Infection

pp 1–11 | Cite as

Analysis of hepatitis B virus-mixed genotype infection by ultra deep pyrosequencing in Sudanese patients, 2015–2016

  • Khalid Abdallah Enan
  • Claudia Minosse
  • Abdel Rahim Mohammed El Hussein
  • Marina Selleri
  • Emanuela Giombini
  • Maria Rosaria Capobianchi
  • Isam Mohamed Elkhidir
  • Mohamed Omer Mustafa
  • Osama Mohamed Khair
  • Dina Ahamed Hassan
  • Anna Rosa GarbugliaEmail author
Original Paper
  • 48 Downloads

Abstract

Purpose

The frequency of detection of HBV co-infection with multiple HBV genotypes is influenced by the detection method; usually co-infections are detected by multiplex PCR or hybridization assays, and are rarely confirmed by sequencing and conventional cloning. The objective of this study was to confirm by ultra-deep pyrosequencing (UDPS) mixed HBV infections, previously detected by multiplex-nested PCR.

Methods

Sixteen samples from HBV co-infected Sudanese patients detected by multiplex-nested PCR, were amplified targeting the P/S region and sequenced by UDPS.

Results

The only genotypes identified using UDPS were D and E, while A, B, C and F genotypes, previously detected by multiplex-nested PCR, were not detected. Specifically, 10 samples were shown to be mono-infected (D or E); in 3 out of 10 mono-infected D patients, a subtype combination was observed: D1 + D7 in 2 cases and D2 + D6 in 1 case. The remaining 6 subjects were D + E co-infected (harboring different mixtures of D subtypes).

Conclusions

Overall, UDPS is more effective than multiplex-nested PCR for identifying multiple HBV genotypes and subtypes infections.

Keywords

Hepatitis B virus High-throughput nucleotide sequencing Sudan Co-infection 

Notes

Acknowledgements

This work was supported by Italian Ministry of Health (funds Ricerca Corrente, linea 3 hepatitis to National Institute for Infectious Diseases INMI IRCCS L. Spallanzani); the European Union’s Horizon 2020 research and innovation program European Virus Archive goes Global under Grant agreement no. 653316.

Compliance with ethical standards

Conflict of interest

All authors declare that they have no conflict of interest.

Supplementary material

15010_2019_1306_MOESM1_ESM.docx (41 kb)
Supplementary material 1 (DOCX 40 kb)

References

  1. 1.
    Kramvis A. Genotypes and genetic variability of hepatitis B virus. Intervirology. 2014;57:141–50.  https://doi.org/10.1159/000360947.CrossRefGoogle Scholar
  2. 2.
    Norder H, Couroucé A-M, Coursaget P, Echevarria JM, Lee S-D, Mushahwar IK, et al. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology. 2004;47:289–309.  https://doi.org/10.1159/000080872.CrossRefGoogle Scholar
  3. 3.
    Santos AO, Alvarado-Mora MV, Botelho L, Vieira DS, Pinho JRR, Carrilho FJ, et al. Characterization of hepatitis B virus (HBV) genotypes in patients from Rondônia, Brazil. Virol J. 2010;7:315.  https://doi.org/10.1186/1743-422X-7-315.CrossRefGoogle Scholar
  4. 4.
    Stuyver L, De Gendt S, Van Geyt C, Zoulim F, Fried M, Schinazi RF, et al. A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol. 2000;81:67–74.  https://doi.org/10.1099/0022-1317-81-1-67.CrossRefGoogle Scholar
  5. 5.
    Arauz-Ruiz P, Norder H, Robertson BH, Magnius LO. Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol. 2002;83:2059–73.  https://doi.org/10.1099/0022-1317-83-8-2059.CrossRefGoogle Scholar
  6. 6.
    Hess G, Arnold W, Koesters W, Biswas R, Hütteroth TH, zum Büschenfelde KH. Simultaneous presence of HBsAg and anti-HBs in the serum of different subtypes (serological and immunofluorescent studies). Z Immunitatsforsch Immunobiol. 1977;153:143–51.CrossRefGoogle Scholar
  7. 7.
    Tabor E, Gerety RJ, Smallwood LA, Barker LF. Coincident hepatitis B surface antigen and antibodies of different subtypes in human serum. J Immunol Baltim Md. 1950;1977:369–70.Google Scholar
  8. 8.
    Ding X, Gu H, Zhong Z-H, Zilong X, Tran HT-T, Iwaki Y, et al. Molecular epidemiology of hepatitis viruses and genotypic distribution of hepatitis B and C viruses in Harbin, China. Jpn J Infect Dis. 2003;56:19–22.Google Scholar
  9. 9.
    Kato H, Orito E, Sugauchi F, Ueda R, Koshizaka T, Yanaka S, et al. Frequent coinfection with hepatitis B virus strains of distinct genotypes detected by hybridization with type-specific probes immobilized on a solid-phase support. J Virol Methods. 2003;110:29–35.CrossRefGoogle Scholar
  10. 10.
    Chen B-F, Kao J-H, Liu C-J, Chen D-S, Chen P-J. Genotypic dominance and novel recombinations in HBV genotype B and C co-infected intravenous drug users. J Med Virol. 2004;73:13–22.  https://doi.org/10.1002/jmv.20051.CrossRefGoogle Scholar
  11. 11.
    Candotti D, Diarra B, Bisseye C, Tao I, Pham Quang K, Sanou M, et al. Molecular characterization of hepatitis B virus in blood donors from Burkina Faso: prevalence of quasi-subgenotype A3, genotype E, and mixed infections. J Med Virol. 2016;88:2145–56.  https://doi.org/10.1002/jmv.24589.CrossRefGoogle Scholar
  12. 12.
    Toan NL, Song LH, Kremsner PG, Duy DN, Binh VQ, Duechting A, et al. Co-infection of human parvovirus B19 in Vietnamese patients with hepatitis B virus infection. J Hepatol. 2006;45:361–9.  https://doi.org/10.1016/j.jhep.2006.03.013.CrossRefGoogle Scholar
  13. 13.
    Minosse C, Giombini E, Bartolini B, Capobianchi MR, Garbuglia AR. Ultra-deep sequencing characterization of HCV samples with equivocal typing results determined with a commercial assay. Int J Mol Sci. 2016;17:1679.  https://doi.org/10.3390/ijms17101679.CrossRefGoogle Scholar
  14. 14.
    Chien R-N, Yeh C-T, Tsai S-L, Chu C-M, Liaw Y-F. Determinants for sustained HBeAg response to lamivudine therapy. Hepatol Baltim Md. 2003;38:1267–73.  https://doi.org/10.1053/jhep.2003.50458.CrossRefGoogle Scholar
  15. 15.
    Kobayashi M, Suzuki F, Akuta N, Suzuki Y, Arase Y, Ikeda K, et al. Response to long-term lamivudine treatment in patients infected with hepatitis B virus genotypes A, B, and C. J Med Virol. 2006;78:1276–83.  https://doi.org/10.1002/jmv.20701.CrossRefGoogle Scholar
  16. 16.
    Osiowy C, Villeneuve J-P, Heathcote EJ, Giles E, Borlang J. Detection of rtN236T and rtA181 V/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2). J Clin Microbiol. 2006;44:1994–7.  https://doi.org/10.1128/JCM.02477-05.CrossRefGoogle Scholar
  17. 17.
    Bonino F, Marcellin P, Lau GKK, Hadziyannis S, Jin R, Piratvisuth T, et al. Predicting response to peginterferon alpha-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B. Gut. 2007;56:699–705.  https://doi.org/10.1136/gut.2005.089722.CrossRefGoogle Scholar
  18. 18.
    Chauhan R, Singh AK, Rooge S, Varshney A, Kumar M, Sarin SK. Analysis of hepatitis B virus genotype changes in patients with chronic hepatitis B infection on tenofovir therapy. J Med Virol. 2016;88:1364–75.  https://doi.org/10.1002/jmv.24489.CrossRefGoogle Scholar
  19. 19.
    Naito H, Hayashi S, Abe K. Rapid and specific genotyping system for hepatitis B virus corresponding to six major genotypes by PCR using type-specific primers. J Clin Microbiol. 2001;39:362–4.  https://doi.org/10.1128/JCM.39.1.362-364.2001.CrossRefGoogle Scholar
  20. 20.
    Caballero A, Gregori J, Homs M, Tabernero D, Gonzalez C, Quer J, et al. Complex genotype mixtures analyzed by deep sequencing in two different regions of hepatitis B virus. PLoS One. 2015;10:e0144816.  https://doi.org/10.1371/journal.pone.0144816.CrossRefGoogle Scholar
  21. 21.
    Vincenti D, Piselli P, Solmone M, D’Offizi G, Capobianchi MR, Menzo S. Evolutionary trends of resistance mutational patterns of HBV reverse transcriptase over years (2002–2012) of different treatment regimens: the legacy of lamivudine/adefovir combination treatment. Antiviral Res. 2017;143:62–8.  https://doi.org/10.1016/j.antiviral.2017.03.008.CrossRefGoogle Scholar
  22. 22.
    Zhang Q, Wu G, Richards E, Jia S, Zeng C. Universal primers for HBV genome DNA amplification across subtypes: a case study for designing more effective viral primers. Virol J. 2007;4:92.  https://doi.org/10.1186/1743-422X-4-92.CrossRefGoogle Scholar
  23. 23.
    Li W, Jaroszewski L, Godzik A. Clustering of highly homologous sequences to reduce the size of large protein databases. Bioinforma Oxf Engl. 2001;17:282–3.CrossRefGoogle Scholar
  24. 24.
    Ramírez C, Gregori J, Buti M, Tabernero D, Camós S, Casillas R, et al. A comparative study of ultra-deep pyrosequencing and cloning to quantitatively analyze the viral quasispecies using hepatitis B virus infection as a model. Antiviral Res. 2013;98:273–83.  https://doi.org/10.1016/j.antiviral.2013.03.007.CrossRefGoogle Scholar
  25. 25.
    Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004;32:1792–7.  https://doi.org/10.1093/nar/gkh340.CrossRefGoogle Scholar
  26. 26.
    Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol. 2013;30:2725–9.  https://doi.org/10.1093/molbev/mst197.CrossRefGoogle Scholar
  27. 27.
    Yousif M, Mudawi H, Bakhiet S, Glebe D, Kramvis A. Molecular characterization of hepatitis B virus in liver disease patients and asymptomatic carriers of the virus in Sudan. BMC Infect Dis. 2013;13:328.  https://doi.org/10.1186/1471-2334-13-328.CrossRefGoogle Scholar
  28. 28.
    Yousif M, Mudawi H, Hussein W, Mukhtar M, Nemeri O, Glebe D, et al. Genotyping and virological characteristics of hepatitis B virus in HIV-infected individuals in Sudan. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2014;29:125–32.  https://doi.org/10.1016/j.ijid.2014.07.002.Google Scholar
  29. 29.
    Mahgoub S, Candotti D, El Ekiaby M, Allain J-P. Hepatitis B virus (HBV) infection and recombination between HBV genotypes D and E in asymptomatic blood donors from Khartoum, Sudan. J Clin Microbiol. 2011;49:298–306.  https://doi.org/10.1128/JCM.00867-10.CrossRefGoogle Scholar
  30. 30.
    Coppola N, Onorato L, Minichini C, Di Caprio G, Starace M, Sagnelli C, et al. Clinical significance of hepatitis B surface antigen mutants. World J Hepatol. 2015;7:2729–39.  https://doi.org/10.4254/wjh.v7.i27.2729.CrossRefGoogle Scholar
  31. 31.
    Lim CK, Tan JTM, Ravichandran A, Chan YC, Ton SH. Comparison of PCR-based genotyping methods for hepatitis B virus. Malays J Pathol. 2007;29:79–90.Google Scholar
  32. 32.
    Sertoz RY, Erensoy S, Pas S, Akarca US, Ozgenc F, Yamazhan T, et al. Comparison of sequence analysis and INNO-LiPA HBV DR line probe assay in patients with chronic hepatitis B. J Chemother Florence Italy. 2005;17:514–20.  https://doi.org/10.1179/joc.2005.17.5.514.CrossRefGoogle Scholar
  33. 33.
    Takahashi K, Akahane Y, Hino K, Ohta Y, Mishiro S. Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients: comparative analysis of 40 full-length isolates. Arch Virol. 1998;143:2313–26.CrossRefGoogle Scholar
  34. 34.
    Venegas M, Muñoz G, Hurtado C, Alvarez L, Velasco M, Villanueva RA, et al. Prevalence of hepatitis B virus genotypes in chronic carriers in Santiago, Chile. Arch Virol. 2008;153:2129–32.  https://doi.org/10.1007/s00705-008-0231-6.CrossRefGoogle Scholar
  35. 35.
    Bekondi C, Olinger CM, Boua N, Talarmin A, Muller CP, Le Faou A, et al. Central African Republic is part of the West-African hepatitis B virus genotype E crescent. J Clin Virol Off Publ Pan Am Soc Clin Virol. 2007;40:31–7.  https://doi.org/10.1016/j.jcv.2007.05.009.CrossRefGoogle Scholar
  36. 36.
    Repp R, Rhiel S, Heermann KH, Schaefer S, Keller C, Ndumbe P, et al. Genotyping by multiplex polymerase chain reaction for detection of endemic hepatitis B virus transmission. J Clin Microbiol. 1993;31:1095–102.Google Scholar
  37. 37.
    Ehrich M, Böcker S, van den Boom D. Multiplexed discovery of sequence polymorphisms using base-specific cleavage and MALDI-TOF MS. Nucleic Acids Res. 2005;33:e38.  https://doi.org/10.1093/nar/gni038.CrossRefGoogle Scholar
  38. 38.
    Bekondi C, Olinger CM, Boua N, Talarmin A, Venard V, Muller CP, et al. Characterization of hepatitis B virus strains from the Central African Republic: preliminary results. Pathol Biol (Paris). 2008;56:310–3.  https://doi.org/10.1016/j.patbio.2007.12.007.CrossRefGoogle Scholar
  39. 39.
    Hübschen JM, Andernach IE, Muller CP. Hepatitis B virus genotype E variability in Africa. J Clin Virol Off Publ Pan Am Soc Clin Virol. 2008;43:376–80.  https://doi.org/10.1016/j.jcv.2008.08.018.CrossRefGoogle Scholar
  40. 40.
    Yousif M, Kramvis A. Genotype D of hepatitis B virus and its subgenotypes: an update. Hepatol Res Off J Jpn Soc Hepatol. 2013;43:355–64.  https://doi.org/10.1111/j.1872-034X.2012.01090.x.CrossRefGoogle Scholar
  41. 41.
    Ochwoto M, Chauhan R, Gopalakrishnan D, Chen C-Y, Nganga Z, Okoth F, et al. Genotyping and molecular characterization of hepatitis B virus in liver disease patients in Kenya. Infect Genet Evol J Mol Epidemiol Evol Genet Infect Dis. 2013;20:103–10.  https://doi.org/10.1016/j.meegid.2013.08.013.Google Scholar
  42. 42.
    Perrillo R. Benefits and risks of interferon therapy for hepatitis B. Hepatol Baltim Md. 2009;49:S103–11.  https://doi.org/10.1002/hep.22956.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Khalid Abdallah Enan
    • 1
  • Claudia Minosse
    • 2
  • Abdel Rahim Mohammed El Hussein
    • 1
  • Marina Selleri
    • 2
  • Emanuela Giombini
    • 2
  • Maria Rosaria Capobianchi
    • 2
  • Isam Mohamed Elkhidir
    • 3
  • Mohamed Omer Mustafa
    • 1
  • Osama Mohamed Khair
    • 3
  • Dina Ahamed Hassan
    • 1
  • Anna Rosa Garbuglia
    • 2
    Email author
  1. 1.Department of Virology, Central LaboratoryThe Ministry of Higher Education and Scientific ResearchKhartoumSudan
  2. 2.Laboratory of VirologyNational Institute for Infectious Diseases “Lazzaro Spallanzani”-IRCCSRomeItaly
  3. 3.Department of Microbiology and Parasitology, Faculty of MedicineUniversity of KhartoumKhartoumSudan

Personalised recommendations